Metabolic Syndrome
Three of five criteria is the clinical threshold. Each one responds to targeted intervention.
At a glance
The letters on this page
Eight interventions on this page. Four carry a letter; four are listed without one, with the reason.
How it is measured
The first five are the harmonized metabolic syndrome criteria; three or more meet the definition (Alberti 2009, PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 19805654). HbA1c A blood test that reflects average blood sugar over the previous two to three months. is the American Diabetes Association prediabetes cutoff (PMID 41358893). These are thresholds for a diagnosis, not treatment goals.
What has been graded
The only intervention that addresses all five metabolic syndrome criteria simultaneously. 150 min/week moderate aerobic plus 2x/week resistance training is the evidence-supported minimum.
Not graded for this use. Combination. EBL grades an intervention at the dose and protocol a trial studied. No trial has studied this combination as a combination, so it carries no letter; the components are graded separately.
Triglyceride lowering is the strongest signal. REDUCE-IT cardiovascular event reduction at 4g/day. Addresses the lipid component of metabolic syndrome directly.
Not graded for this use. Omega-3's graded uses are cardiovascular event endpoints, not triglycerides as an endpoint.
Insulin sensitivity, blood pressure, and glucose metabolism. Over 50% of adults with metabolic syndrome are magnesium insufficient. RBC magnesium is a more accurate measure than serum.
AMPK activation. Multiple RCTs Randomized controlled trial: people are assigned to the treatment or a comparison by chance, so the groups differ only in what they received. It is the design that can show cause and effect. show HbA1c reduction, LDL Low-density lipoprotein cholesterol, the cholesterol fraction most closely tied to plaque in the arteries. lowering, and triglyceride reduction. Some head-to-head trials show effects comparable to low-dose metformin. Combining with metformin belongs under physician supervision.
Deficiency is strongly linked to metabolic syndrome prevalence. Correction of deficiency improves insulin sensitivity and blood pressure. No optimal serum concentration is established; the National Academies sufficiency cutpoint is 20 ng/mL.
Not graded for this use. None of vitamin D's graded uses covers metabolic syndrome.
LDL reduction, glucose blunting post-meal, and modest triglyceride lowering. It is taken with water, usually 30 minutes before meals. Gastrointestinal effects are the side effect most often reported.
The only cited trial in metabolic syndrome (PMID 25618800) tested a curcuminoid-piperine combination, so it cannot isolate curcumin.
Not graded for this use. Curcumin's graded uses are systemic inflammatory markers and knee osteoarthritis pain and function. The only cited trial in metabolic syndrome (PMID 25618800) tested a curcuminoid-piperine combination, so it cannot isolate curcumin.
Cautions
- •Berberine adds to the glucose-lowering effect of metformin, sulfonylureas and other diabetes medications, raising the risk of low blood sugar. Any dose change is a decision for the prescriber.
- •Statins lower circulating CoQ10. Whether that reflects a tissue deficit that matters clinically is unsettled, and the 2026 ACC/AHA dyslipidemia guideline advises against routine CoQ10 for statin-attributed muscle symptoms.
- •Some thiazide diuretics and beta-blockers can worsen insulin resistance and raise triglycerides. Worsening metabolic markers are a reason for a medication review with your physician.
- •GLP-1 receptor agonists such as semaglutide and liraglutide are used for diabetes and/or obesity, conditions that commonly overlap with metabolic syndrome. Adding glucose-lowering supplements to glucose-lowering medication is a decision for your physician.
This page is educational only. Metabolic syndrome diagnosis requires clinical measurement of all five criteria. Before starting berberine, discuss with your physician if you are on any diabetes or cholesterol medications. The Drug-Nutrient Depletion tool checks current medications.
Disclosure
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.